BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31217941)

  • 1. Chronic myelomonocytic leukemia associated with myeloid sarcomas and
    Matanes F; AbdelAzeem BMA; Shah G; Reddy V; Saad A; Papadantonakis N
    Ther Adv Hematol; 2019; 10():2040620719854596. PubMed ID: 31217941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infrequent Presentations of Chronic
    Castaño-Díez S; Guijarro F; López-Guerra M; Pérez-Valencia AI; Gómez-Núñez M; Colomer D; Díaz-Beyá M; Esteve J; Rozman M
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation.
    Peng J; Zuo Z; Fu B; Oki Y; Tang G; Goswami M; Priyanka P; Muzzafar T; Medeiros LJ; Luthra R; Wang SA
    Eur J Haematol; 2016 Jan; 96(1):65-71. PubMed ID: 25809997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern associated leukemia immunophenotypes and measurable disease detection in acute myeloid leukemia or myelodysplastic syndrome with mutated NPM1.
    Zhou Y; Moon A; Hoyle E; Fromm JR; Chen X; Soma L; Salipante SJ; Wood BL; Wu D
    Cytometry B Clin Cytom; 2019 Jan; 96(1):67-72. PubMed ID: 30417521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
    Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J
    Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
    Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
    Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders.
    Caudill JS; Sternberg AJ; Li CY; Tefferi A; Lasho TL; Steensma DP
    Br J Haematol; 2006 Jun; 133(6):638-41. PubMed ID: 16704439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic myelomonocytic leukemia: myeloproliferative variant.
    Onida F; Beran M
    Curr Hematol Rep; 2004 May; 3(3):218-26. PubMed ID: 15087071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Acute Kidney Injury Associated with Transformation of Chronic Myelomonocytic Leukemia into Acute Myeloid Leukemia: A Case Report.
    Lee SW; Kim MS; Kim YJ; Jung HY; Choi JY; Cho JH; Park SH; Kim CD; Kim YL; Lim JH
    J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
    Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
    Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype.
    Huh YO; Tang G; Talwalkar SS; Khoury JD; Ohanian M; Bueso-Ramos CE; Abruzzo LV
    Cancer Genet; 2016; 209(7-8):313-20. PubMed ID: 27318442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia.
    Loghavi S; Curry JL; Garcia-Manero G; Patel KP; Xu J; Khoury JD; Torres-Cabala CA; Nagarajan P; Aung PP; Gibson BR; Goodwin BP; Kelly BC; Korivi BR; Medeiros LJ; Prieto VG; Kantarjian HM; Bueso-Ramos CE; Tetzlaff MT
    J Cutan Pathol; 2017 Dec; 44(12):1075-1079. PubMed ID: 28885734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasculitis in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia: A Report of Two Cases.
    Jacobse J; Sijpkens YWJ; van 't Wout JW; Peters EEM; Vlasveld LT
    J Hematol; 2018 Dec; 7(4):158-162. PubMed ID: 32300432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of chronic myelomonocytic leukemia complicated with spondyloarthritis.
    Matsumoto T; Saito T; Kohsaka H
    Mod Rheumatol; 2018 Mar; 28(2):373-375. PubMed ID: 26392142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic significance of early assessment of minimal residual disease in acute myeloid leukemia with mutated NPM1 patients].
    Zhao T; Zhu HH; Wang J; Jia JS; Yang SM; Jiang H; Lu J; Chen H; Xu LP; Zhang XH; Jiang B; Ruan GR; Wang DB; Huang XJ; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2017 Jan; 38(1):10-16. PubMed ID: 28219218
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcome of patient with high-risk chronic myelomonocytic leukemia, treated with decitabine prior to transformation to acute myeloid leukemia: A case report.
    Liu H; Cheng J; Zhao L; Xu Q; Xue M; Zhang S; Liu B
    Oncol Lett; 2018 May; 15(5):7132-7138. PubMed ID: 29731877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of myeloid sarcoma with correlation to JAK2V617F mutation, complicated by myelofibrosis and secondary acute myeloid leukemia.
    Yoshiki Y; Asai T; Ichikawa M; Hangaishi A; Ota S; Imai Y; Takahashi T; Kurokawa M
    Intern Med; 2011; 50(21):2649-52. PubMed ID: 22041374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia.
    Edlin R; Connock M; Tubeuf S; Round J; Fry-Smith A; Hyde C; Greenheld W
    Health Technol Assess; 2010 May; 14 Suppl 1():69-74. PubMed ID: 20507806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous leukemic clones identified by NPM1 mutation analysis in patient with acute monocytic leukemia.
    Qiao C; Zhang R; Hong M; Wang L; Zhang JF; Wu YJ; Qiu HR; Qiu HX; Qian SX; Lu H; Zhang SJ; Li JY
    Leuk Lymphoma; 2012 May; 53(5):886-90. PubMed ID: 22035378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis.
    Hu Z; Hu S; Ji C; Tang Z; Thakral B; Loghavi S; Medeiros LJ; Wang W
    Leuk Res; 2018 Feb; 65():25-28. PubMed ID: 29288910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.